- Home
- APLS vs FBK Comparison
APLS vs FBK Comparison
Compare APLS & FBK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- APLS
- FBK
- Stock Information
- Founded
- APLS 2009
- FBK 1906
- Country
- APLS United States
- FBK United States
- Employees
- APLS N/A
- FBK N/A
- Industry
- APLS Biotechnology: Pharmaceutical Preparations
- FBK Major Banks
- Sector
- APLS Health Care
- FBK Finance
- Exchange
- APLS Nasdaq
- FBK Nasdaq
- Market Cap
- APLS 2.3B
- FBK 2.0B
- IPO Year
- APLS 2017
- FBK 2016
- Fundamental
- Price
- APLS $17.30
- FBK $45.22
- Analyst Decision
- APLS Buy
- FBK Hold
- Analyst Count
- APLS 19
- FBK 5
- Target Price
- APLS $39.06
- FBK $54.00
- AVG Volume (30 Days)
- APLS 2.7M
- FBK 283.2K
- Earning Date
- APLS 05-07-2025
- FBK 04-14-2025
- Dividend Yield
- APLS N/A
- FBK 1.67%
- EPS Growth
- APLS N/A
- FBK 14.69
- EPS
- APLS N/A
- FBK 2.73
- Revenue
- APLS $775,839,000.00
- FBK $465,280,000.00
- Revenue This Year
- APLS $12.25
- FBK $35.47
- Revenue Next Year
- APLS $21.08
- FBK $20.14
- P/E Ratio
- APLS N/A
- FBK $16.65
- Revenue Growth
- APLS 48.04
- FBK 2.18
- 52 Week Low
- APLS $16.65
- FBK $34.50
- 52 Week High
- APLS $43.99
- FBK $58.88
- Technical
- Relative Strength Index (RSI)
- APLS 34.14
- FBK 58.36
- Support Level
- APLS $16.65
- FBK $43.73
- Resistance Level
- APLS $20.75
- FBK $45.78
- Average True Range (ATR)
- APLS 1.09
- FBK 1.03
- MACD
- APLS 0.14
- FBK 0.56
- Stochastic Oscillator
- APLS 15.85
- FBK 90.00
About APLS Apellis Pharmaceuticals Inc.
Apellis Pharmaceuticals Inc is a commercial-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel therapeutic compounds to treat diseases with high unmet needs through the inhibition of the complement system, which is an integral component of the immune system, at the level of C3, the central protein in the complement cascade.
About FBK FB Financial Corporation
FB Financial Corp is a bank holding company. The company through its wholly-owned bank subsidiary provides commercial and consumer banking services to clients in select markets in Tennessee, North Alabama, and North Georgia. The company segment includes Banking and Mortgage. It generates revenue from the Banking segment which provides a full range of deposit and lending products and services to corporate, commercial, and consumer customers. The Mortgage segment includes the servicing of residential mortgage loans and the packaging and securitization of loans to governmental agencies.